Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESTORE: Dextenza for Post-PRK Inflammation and Pain
NCT04396990Phase 4Completed
- Sponsor
- Vance Thompson Vision
- Start
- Jun 2020
- Primary completion
- Sep 2020
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in postoperative pain, post-operative inflammation, sponsored by Vance Thompson Vision. Started Jun 2020; status: completed.
02
Drugs
ozurdex
03
Conditions
postoperative painpost-operative inflammation
Beyond the preview
Go deeper on NCT04396990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04396990.